President, Head of Research & Development
Alector
South San Francisco, California
Sara Kenkare-Mitra, Ph.D., currently serves as President and Head of R&D at Alector, leading all aspects of the company’s immuno-neurology and oncology R&D efforts.
Prior to Alector, Sara held roles of increasing responsibility at Genentech over the course of 23 years, most recently serving as Senior Vice President, Development Sciences, where she led a global organization of approximately 650 employees, and played a key role in the filing of more than 100 Investigational New Drug/clinical trial applications, and approval of 15 medicines for diverse diseases.
Sara received her Ph.D. in Pharmaceutical Chemistry from the University of California, San Francisco (UCSF), where she also was a Post-Doctoral Fellow in the school of medicine and completed a Fellowship in Clinical Pharmacology. She is an elected member of the National Academy of Medicine (NAM) and elected Fellow of the Association for the Advancement of Science (AAAS). She has been recognized for her work in the industry with awards such as the American Association of Pharmaceutical Scientists’ Alice E. Till Advancement of Women in Pharmaceutical Sciences Recognition, Endpoints’ 20 Most Extraordinary Women in Biopharma, Fierce Pharma’s Fiercest Women in the Life Sciences, and the University of California, San Francisco’s Distinguished Alumnus of the Year.
Disclosure information not submitted.
Monday, October 17, 2022
1:30 PM – 2:30 PM ET